null

SMILES: OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1ccc(nc1)-n1cnc(c1)C(F)(F)F)C1CCCC1

InChI Key: InChIKey=KZWVSKJOXJGUQM-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 100794   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Pro-glucagon (Homo sapiens (Human))	BDBM100794 (US8507533, 300 | US8507533, 97 | US8507533, 98) Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1ccc(nc1)-n1cnc(c1)C(F)(F)F)C1CCCC1 Show InChI InChI=1S/C25H26F3N5O3/c26-25(27,28)20-14-33(15-31-20)21-10-9-19(13-30-21)32-23(16-3-1-2-4-16)17-5-7-18(8-6-17)24(36)29-12-11-22(34)35/h5-10,13-16,23,32H,1-4,11-12H2,(H,29,36)(H,34,35)	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	1.10E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.				US Patent US8507533 (2013) BindingDB Entry DOI: 10.7270/Q23R0RGH
					More data for this Ligand-Target Pair
Pro-glucagon (Homo sapiens (Human))	BDBM100794 (US8507533, 300 | US8507533, 97 | US8507533, 98) Show SMILES OC(=O)CCNC(=O)c1ccc(cc1)C(Nc1ccc(nc1)-n1cnc(c1)C(F)(F)F)C1CCCC1 Show InChI InChI=1S/C25H26F3N5O3/c26-25(27,28)20-14-33(15-31-20)21-10-9-19(13-30-21)32-23(16-3-1-2-4-16)17-5-7-18(8-6-17)24(36)29-12-11-22(34)35/h5-10,13-16,23,32H,1-4,11-12H2,(H,29,36)(H,34,35)	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	93	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.				US Patent US8507533 (2013) BindingDB Entry DOI: 10.7270/Q23R0RGH
					More data for this Ligand-Target Pair